High frequency of CD90/Thy-1 expression on blast cells of myelodysplastic syndromes and high risk acute myeloid leukemias.

被引：0
|
作者：
Buccisano, F
Rossi, FM
Venditti, A
Del Poeta, G
Rupolo, M
Berretta, M
Cox, MC
Abbruzzese, E
Tamburini, A
Maurillo, L
Amadori, S
Gattei, V
机构：
[1] Univ Roma Tor Vergata, I-00173 Rome, Italy
[2] IRCCS, Ctr Riferimento Oncol, Clin & Expt Hematol Res Unit, Aviano, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
733
引用
收藏
页码：195A / 195A
页数：1
相关论文
共 50 条
  • [31] Implications of high EVI1 expression in high-risk myelodysplastic syndromes
    Abedin, Sameem
    Platanias, Leonidas C.
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 2765 - 2766
  • [32] WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Giudice, Valentina
    Gorrese, Marisa
    Vitolo, Rosa
    Bertolini, Angela
    Marcucci, Rossella
    Serio, Bianca
    Guariglia, Roberto
    Ferrara, Idalucia
    Pepe, Rita
    D'Alto, Francesca
    Izzo, Barbara
    Pedicini, Antonio
    Montuori, Nunzia
    Langella, Maddalena
    Selleri, Carmine
    BIOMEDICINES, 2021, 9 (04)
  • [33] Anomalous expression of Thy1 (CD90) in B-cell lymphoma cells and proliferation inhibition by anti-Thy1 antibody treatment
    Ishiura, Yoshihito
    Kotani, Norihiro
    Yamashita, Ryusuke
    Yamamoto, Harumi
    Kozutsumi, Yasunori
    Honke, Koichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (02) : 329 - 334
  • [34] Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics
    Campioni, D.
    Lanza, F.
    Moretti, S.
    Ferrari, L.
    Cuneo, A.
    CYTOTHERAPY, 2008, 10 (01) : 69 - 82
  • [35] Peripheral CD4+ T cell maturation recognized by increased expression of Thy-1/CD90 bearing the 6C10 carbohydrate epitope
    Gui, M
    Wiest, DL
    Li, J
    Kappes, D
    Hardy, RR
    Hayakawa, K
    JOURNAL OF IMMUNOLOGY, 1999, 163 (09): : 4796 - 4804
  • [36] Intensive chemotherapy for patients with high risk myelodysplastic syndromes (MDS) and acute myeloid leukemia.
    Shi, J
    Shao, ZH
    Liu, H
    Chen, GB
    Song, LY
    Zhang, YZ
    Li, K
    Fu, R
    Zhao, MF
    He, GS
    Bar, J
    Chu, YL
    Yang, TY
    BLOOD, 2002, 100 (11) : 336B - 336B
  • [37] Leukocyte adhesion to activated endothelial cells mediated by the interaction between Thy-1 (CD90) and Mac-1 (CD11b/CD18) - a competition for ICAM-1?
    Wetzel, A
    Sticherling, M
    Haustein, UF
    Anderegg, U
    Saalbach, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
  • [38] Expression of DDIT4 Is Correlated with NOTCH1 and High Molecular Risk in Acute Myeloid Leukemias
    Pinto, Joseph A.
    Bravo, Leny
    Chirinos, Luis A.
    Vigil, Carlos E.
    BLOOD, 2016, 128 (22)
  • [39] A phase I/II study of topotecan, mitoxantrone and etoposide in relapsed/refractory acute myeloid leukemia (AML), myeloid blast crisis and high risk myelodysplastic syndromes (MDS).
    Nand, S
    Stiff, P
    Beltran, O
    Godwin, J
    BLOOD, 1999, 94 (10) : 234B - 234B
  • [40] Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes
    Gayoso, Jorge
    Balsalobre, Pascual
    Kwon, Mi
    Herrera, Pilar
    Bermudez, Arancha
    Sampol, Antonia
    Jimenez, Santiago
    Lopez-Corral, Lucia
    Serrano, David
    Luis Pinana, Jose
    Pascual, Maria J.
    Heras, Inmaculada
    Bento, Leyre
    Varela, Rosario
    Humala, Karem
    Zabalza, Amaya
    Laiglesia, Almudena
    Bastos-Oreiro, Mariana
    Perez-Corral, Ana
    Martinez-Laperche, Carolina
    Buno, Ismael
    Diez-Martin, Jose L.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 332 - 339
12345